FMRI-neurofeedback in Depression
Sponsor: Maastricht University Medical Center • ClinicalTrials.gov ID: NCT05640089
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Previous studies with fMRI-neurofeedback in depression have demonstrated a good safety profile and considerable symptom reduction. The goal of this clinical trial is to compare fMRI-neurofeedback plus standard care with standard care in patients with depression. Participants will either receive standard care, or standard care plus a fMRI neurofeedback training, consisting of 5 neurofeedback training sessions. Symptom severity will be assessed before, immediately after and 6 months after the intervention.
Interventions
-
fMRI-based neurofeedback
(Other)
Participants use fMRI-based neurofeedback to train the upregulation of brain areas that respond to positive affective pictures (as identified during a functional localiser scan).
Eligibility criteria
Conditions
Locations
- Mondriaan Zorggroep — Maastricht, Netherlands
- Maastricht University — Maastricht, Netherlands
- Maastricht UMC+ — Maastricht, Netherlands
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record